Difference in serum cytokines between metastatic colorectal cancer patients with mutant and wild type RAS in response to targeted treatment with monoclonal antibodies
Cytokines and chemokines play dual – pro- and antioncogenic – roles in tumor progression. Targeted medications of monoclonal antibodies, anti-VEGF (bevacizumab) and anti-EGFR (cetuximab, panitumumab), are widely used in treatment of metastatic colorectal cancer (mCRC) and are prescribed in dependenc...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2024-07-01
|
| Col·lecció: | Медицинская иммунология |
| Matèries: | |
| Accés en línia: | https://www.mimmun.ru/mimmun/article/view/3057 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|